Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SANUWAVE Health (SNWV) EPS (Weighted Average and Diluted) (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed EPS (Weighted Average and Diluted) for 7 consecutive years, with $0.78 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 169.64% to $0.78 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.41 through Dec 2025, up 105.28% year-over-year, with the annual reading at $0.41 for FY2025, 105.53% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $0.78 at SANUWAVE Health, up from $0.39 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $0.78 in Q4 2025, with the low at -$6.65 in Q3 2024.
  • Average EPS (Weighted Average and Diluted) over 3 years is -$0.88, with a median of -$0.04 recorded in 2025.
  • The sharpest move saw EPS (Weighted Average and Diluted) tumbled 22066.67% in 2024, then surged 169.64% in 2025.
  • Over 3 years, EPS (Weighted Average and Diluted) stood at -$0.03 in 2023, then plummeted by 3633.33% to -$1.12 in 2024, then soared by 169.64% to $0.78 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at $0.78, $0.39, and -$0.04 for Q4 2025, Q3 2025, and Q2 2025 respectively.